heart disease, pneumopathy and hypothyroidism. Post-COVID insomnia, pre-COVID heart disease regardless of the groups with a prevalence of 9.9% with a p = 0.041. Patients with cognitive complaints had a 68.4% prevalence of insomnia p = 0.015. In patients with anxiety, the prevalence of insomnia was 68% p = 0.001.
ConclusionsThe symptoms found during COVID-19 in our population are similar to those published in the international literature. The patients with the highest prevalence of insomnia were have pre-COVID heart disease, anxiety, and cognitive complaints.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.